Chlormethiazole in Treatment of Status Epilepticus
Overview
Authors
Affiliations
Chlormethiazole (Heminevrin) was successful in controlling fits in seven out of nine episodes of intractable status epilepticus. It was administered as a constant intravenous injection at rates of up to 0.7g/h. No serious side effects were encountered, and the drug deserves wider recognition as a useful therapeutic agent in the management of status epilepticus.
Pharmacotherapy for Status Epilepticus.
Trinka E, Hofler J, Leitinger M, Brigo F Drugs. 2015; 75(13):1499-521.
PMID: 26310189 PMC: 4559580. DOI: 10.1007/s40265-015-0454-2.
The pharmacology of chlormethiazole: a potential neuroprotective agent?.
Wilby M, Hutchinson P CNS Drug Rev. 2004; 10(4):281-94.
PMID: 15592579 PMC: 6741715. DOI: 10.1111/j.1527-3458.2004.tb00028.x.
Tonic clonic status epilepticus.
Shorvon S J Neurol Neurosurg Psychiatry. 1993; 56(2):125-34.
PMID: 8436999 PMC: 1014809. DOI: 10.1136/jnnp.56.2.125.
Problems with intravenous chlormethiazole (Heminevrin) in status epilepticus.
Lingam S, Bertwistle H, Elliston H, Wilson J Br Med J. 1980; 280(6208):155-6.
PMID: 7357299 PMC: 1600378. DOI: 10.1136/bmj.280.6208.155-a.
Oral chlormethiazole in childhood epilepsy.
Stanley T Arch Dis Child. 1982; 57(3):242-3.
PMID: 7073310 PMC: 1627587. DOI: 10.1136/adc.57.3.242-b.